These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33487431)

  • 21. Heart Transplantation for Hepatitis C Virus Non-Viremic Recipients From Hepatitis C Virus Viremic Donors.
    Frager SZ; Dhand A; Gass A; Levine A; Spielvogel D; Nog R; Wolf DC; Bodin RI
    Cardiol Rev; 2019; 27(4):179-181. PubMed ID: 31180937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change.
    Kling CE; Perkins JD; Landis CS; Limaye AP; Sibulesky L
    Am J Transplant; 2017 Nov; 17(11):2863-2868. PubMed ID: 28688205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.
    Bekki Y; Crismale JF; Myers B; Schiano TD; Florman S
    Transplantation; 2022 Sep; 106(9):1787-1798. PubMed ID: 35507448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Over 1000 Heart Transplants Using Hepatitis C-Positive Donors in the Modern Era.
    Kwon JH; Hill MA; Patel R; Tedford RJ; Hashmi ZA; Shorbaji K; Huckaby LV; Welch BA; Kilic A
    Ann Thorac Surg; 2023 Feb; 115(2):493-500. PubMed ID: 36368348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
    Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
    J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney transplant from HCV viremic donors to HCV-negative recipients and risk for de novo donor specific antibodies and acute rejection.
    Daloul R; Sureshkumar K; Schnelle K; Von Stein L; Logan A; Pesavento T
    Clin Transplant; 2023 Feb; 37(2):e14895. PubMed ID: 36580971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors.
    Nguyen T; Sise ME; Delgado C; Williams W; Reese P; Goldberg D
    Transplantation; 2021 Aug; 105(8):1850-1857. PubMed ID: 33141804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accepting hepatitis C virus-infected donor hearts for transplantation: Multistep consent, unrealized opportunity, and the Stanford experience.
    Moayedi Y; Gulamhusein AF; Ross HJ; Teuteberg JJ; Khush KK
    Clin Transplant; 2018 Jul; 32(7):e13308. PubMed ID: 29869354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
    Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
    Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local and regional variability in utilization and allocation of hepatitis C virus-infected hearts for transplantation.
    Prakash K; Wainana C; Trageser J; Hahn A; Lay C; Pretorius V; Adler E; Aslam S
    Am J Transplant; 2020 Oct; 20(10):2867-2875. PubMed ID: 32185860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
    Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
    Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor Hearts.
    Hong Y; Couper CD; Iyanna N; Hess NR; Ziegler LA; Abdullah M; Mathier MA; Hickey GW; Keebler ME; Silvestry SC; Kaczorowski D
    Transplantation; 2024 Sep; ():. PubMed ID: 39228015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
    Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
    Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors.
    Reyentovich A; Gidea CG; Smith D; Lonze B; Kon Z; Fargnoli A; Pavone J; Rao S; Saraon T; Lewis T; Qian Y; Jacobson I; Moazami N
    Clin Transplant; 2020 Sep; 34(9):e13989. PubMed ID: 32441413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
    N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients.
    Zhu Y; Shudo Y; Lee R; Woo YJ
    Ann Transplant; 2020 Jun; 25():e922723. PubMed ID: 32527989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C-Positive Donors in Cardiac Transplantation: Problems and Opportunities.
    Rochlani Y; Diab K; Jorde UP
    Curr Heart Fail Rep; 2020 Aug; 17(4):106-115. PubMed ID: 32474734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.